TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 40 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,215,000 | -40.0% | 18,308,826 | -6.7% | 0.00% | – |
| Q4 2021 | $7,021,000 | -27.0% | 19,626,980 | +22.6% | 0.00% | – |
| Q3 2021 | $9,622,000 | -45.0% | 16,006,620 | +1.5% | 0.00% | – |
| Q2 2021 | $17,501,000 | -6.9% | 15,766,539 | +7.4% | 0.00% | -100.0% |
| Q1 2021 | $18,788,000 | +1433.7% | 14,678,162 | +708.3% | 0.00% | – |
| Q4 2020 | $1,225,000 | +182.9% | 1,815,839 | +252.3% | 0.00% | – |
| Q3 2020 | $433,000 | +85.0% | 515,459 | +34.6% | 0.00% | – |
| Q2 2020 | $234,000 | -14.0% | 383,084 | 0.0% | 0.00% | – |
| Q1 2020 | $272,000 | – | 383,084 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 734,477 | $441,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 516,218 | $310,000 | 0.03% |
| Game Plan Financial Advisors, LLC | 27,216 | $16,000 | 0.01% |
| MONECO Advisors, LLC | 35,000 | $21,000 | 0.01% |
| Purus Wealth Management, LLC | 15,000 | $9,000 | 0.01% |
| Renaissance Technologies | 6,038,664 | $3,630,000 | 0.01% |
| Qube Research & Technologies Ltd | 540,878 | $325,000 | 0.00% |
| D. E. Shaw & Co., Inc. | 6,690,867 | $4,022,000 | 0.00% |
| Cutter & CO Brokerage, Inc. | 19,000 | $11,000 | 0.00% |
| Van Hulzen Asset Management, LLC | 18,200 | $11,000 | 0.00% |